Liposomes conjugated with anti-PLK1 antibodies specifically target the overexpressed PLK1 protein, which is closely related to cell cycle regulation. This targeted delivery system allows anticancer drugs to act more efficiently on melanoma cells, inhibiting their proliferation. This method not only reduces the impact on normal cells but also lowers the side effects of treatment.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-2123z | Mouse Anti-PLK1 Recombinant Antibody (clone 35A5) | WB, ELISA, FC, IHC | Mouse IgG1 |
MRO-2361-CN | Recombinant Rabbit Anti-PLK1 (phosphorylated Thr210) Monoclonal Antibody (CBACN-649) | WB, IF, FC | Rabbit IgG |
ZG-474C | Mouse Anti-PLK1 Recombinant Antibody (clone 2F2F2) | WB | Mouse IgG1, κ |
VS3-QX888 | Mouse Anti-PLK1 Recombinant Antibody (clone 1D1) | WB, IHC, ICC, FC, ELISA | Mouse IgG1 |
VS3-QX889 | Mouse Anti-PLK1 Recombinant Antibody (clone 1F8-E9-E10) | WB, IHC, ICC, FC, ELISA | Mouse IgG1 |
There are currently no Customer reviews or questions for VS-1024-FY197. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.